These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 36378354

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. MALDI-TOF mass spectrometry identification and antifungal susceptibility testing of yeasts causing vulvovaginal candidiasis (VVC) in Tebessa (Northeastern Algeria).
    Benhadj M, Menasria T, Ranque S.
    Ann Biol Clin (Paris); 2024 Feb 24; 81(6):576-584. PubMed ID: 38189374
    [Abstract] [Full Text] [Related]

  • 28. Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy.
    Goswami D, Goswami R, Banerjee U, Dadhwal V, Miglani S, Lattif AA, Kochupillai N.
    J Infect; 2006 Feb 24; 52(2):111-7. PubMed ID: 15908007
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Up-regulation of CDR1 and MDR1 efflux pump genes and fluconazole resistance are involved in recurrence in Candida albicans-induced vulvovaginal candidiasis.
    Esfahani A, Omran AN, Salehi Z, Shams-Ghahfarokhi M, Ghane M, Eybpoosh S, Razzaghi-Abyaneh M.
    Diagn Microbiol Infect Dis; 2024 May 24; 109(1):116242. PubMed ID: 38452558
    [Abstract] [Full Text] [Related]

  • 31. In vivo activity of Sapindus saponaria against azole-susceptible and -resistant human vaginal Candida species.
    Damke E, Tsuzuki JK, Cortez DA, Ferreira IC, Bertoni TA, Batista MR, Donati L, Svidzinski TI, Consolaro ME.
    BMC Complement Altern Med; 2011 May 04; 11():35. PubMed ID: 21542936
    [Abstract] [Full Text] [Related]

  • 32. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S, Santos ALS, Roudbary M, Hadighi R, Falahati M, Farahyar S, Khoshmirsafa M, Kalantari S.
    Lett Appl Microbiol; 2018 Oct 04; 67(4):392-399. PubMed ID: 30019443
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Prevalence, antifungal susceptibility and etiology of vulvovaginal candidiasis in sub-Saharan Africa: a systematic review with meta-analysis and meta-regression.
    Mushi MF, Olum R, Bongomin F.
    Med Mycol; 2022 Jul 09; 60(7):. PubMed ID: 35781514
    [Abstract] [Full Text] [Related]

  • 39. Antifungal Susceptibility Profile of Candida Albicans Isolated from Vulvovaginal Candidiasis in Xinjiang Province of China.
    Yan L, Wang XD, Seyedmousavi S, Yuan JN, Abulize P, Pan WH, Yu N, Yang YL, Hu HQ, Liao WQ, Deng SW.
    Mycopathologia; 2019 Jun 09; 184(3):413-422. PubMed ID: 30968320
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.